US Patent Issued to STEMSYNERGY THERAPEUTICS on Feb. 10 for "MYC inhibitors and uses thereof" (Tennessee, Florida Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,654, issued on Feb. 10, was assigned to STEMSYNERGY THERAPEUTICS INC. (Miami).

"MYC inhibitors and uses thereof" was invented by Darren Orton (Nashville, Tenn.), Dennis Liang Fei (Miami), Samir Saleh (Nashville, Tenn.) and Thomas Doundoulakis (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein, inter alia, are compounds for inhibiting N-MYC or Aurora A Kinase and uses thereof."

The patent was filed on Feb. 10, 2021, under Application No. 17/798,017.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fse...